WHC is still in active development. Read this to understand our approach.
depiction of LSSUMOWDTKZHHT-UHFFFAOYSA-N.svg
tripsit

det

Verificar en tripsit

psychonaut

DET

Verificar en psychonaut

isomerdesign

DET

Verificar en isomerdesign

druglab

DET

Verificar en druglab

drugmap

N,N-diethyl-2-(1H-in...

Verificar en drugmap

wiki

Diethyltryptamine

Verificar en wiki

Data

InChI: InChI=1S/C14H20N2/c1-3-16(4-2)10-9-12-11-15-14-8-6-5-7-13(12)14/h5-8,11,15H,3-4,9-10H2,1-2H3

Sinónimos: BDBM50094676,ADAL1291750,N,N-Diethyl-2-(1H-indol-3-yl)ethanamine, CTK5B3364,3-[2-(Diethylamino)ethyl]indole, ZINC1999162, DTXSID9052763,AKOS005444987, BRN 0153320,5-22-10-00050 (Beilstein Handbook Reference),DET,Diethyltryptamine,916E8V4S2V,Diethyl-[2-(1H-indol-3-yl)-ethyl]-amine,STK368075,diethyl[2-(1H-indol-3-yl)ethyl]amine,BRN 0153320, INDOLE, 3-(2-(DIETHYLAMINO)ETHYL)-,BDBM50094676,DTXSID9052763,Indole, 3-[2-(diethylamino)ethyl],D.E.T.,NN-Diethyltryptamine,diethyltryptamine,3-(2-(DIETHYLAMINO)ETHYL)INDOLE, STK368075,CHEBI:184081, 1H-Indole-3-ethanamine, N,N-diethyl-, AC1L1LS6,DB01460, 3-(2-Diethylaminoethyl)indole,INDOLE, 3-(2-(DIETHYLAMINO)ETHYL)-, LSSUMOWDTKZHHT-UHFFFAOYSA-N,Tryptamine, N,N-diethyl,DEA No. 7434,T-9, N,N-Diethyltryptamine, Oprea1_105894, CHEMBL142936,Q2617768,N,N-Diethyltryptamine, 1H-Indole-3-ethanamine,N,N-diethyl-, D.E.T., AKOS005444987,CHEMBL142936, 61-51-8,61-51-8, 63938-63-6 (mono-hydrochloride),UNII-916E8V4S2V,3-(2-Diethylaminoethyl)indole, DEA No. 7434, UNII-916E8V4S2V, 916E8V4S2V,Oprea1_105894, N,N-Diethyl-2-(1H-indol-3-yl)ethanamine, SCHEMBL517713,N,N-Diethyl-2-(1H-indol-3-yl)ethanamine #, 5-22-10-00050 (Beilstein Handbook Reference),1H-Indole-3-ethanamine, N,N-diethyl-,SCHEMBL517713,N-Ethyl-N-[2-(1H-indol-3-yl)ethyl]ethanamine

Estimated data

Solubilidad: -1.988 (log(S) in mol/L prediction using SolTranNet)

Blood Brain Barrier Permeability: Yes (prediction using frontiersin.org)

Addictivity Prediction: 93.7% (prediction based on www.mdpi.com)

Similitudes

The following is a set of comparisons to understand the properties of this compound. This is still higly experimental and is still under active development. Please refer to our series of blog posts to fully understand our approach and its limitations. This information is for informational purposes only and should not be construed as medical advice.